Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
EDGE-Gastric Trial: Domvanalimab, Zimberelimab, and FOLFOX for First-line Advanced Gastroesophageal Cancer
Dr. Marc Bonaca on the VOYAGER PAD Study
ATG Is an Effective Prophylaxis Against GVHD in Myelofibrosis Patients Undergoing Transplant